Literature DB >> 11451385

Expression of Ca2+/calmodulin-dependent protein kinase II delta-subunit isoforms in rats with hypertensive cardiac hypertrophy.

D Hagemann1, J Bohlender, B Hoch, E G Krause, P Karczewski.   

Abstract

Myocardial hypertrophy is characterized by abnormal intracellular Ca2+ handling and decreased contractile performance. Ca2+/calmodulin-dependent protein kinase II (CaMKII) phosphorylates numerous Ca2+ handling proteins and thus can regulate intracellular Ca2+ homeostasis directly. We therefore investigated whether differential expression of CaMKII isoforms occurs with cardiac hypertrophy which might promote an abnormal intracellular Ca2+ homeostasis. We further investigated the potential influence of angiotensin (Ang) II on CaMKII expression levels. Hearts from adult Spontaneously Hypertensive Rats (SHR) and hearts from two transgenic rat models with Ang II-dependent hypertension were studied. The expression of the cardiac CaMKII isoforms delta2, delta3, delta4 and delta9 was determined by RT-PCR and immunoblot methods. Rats transgenic for the mouse Ren-2 gene (mrTGR), SHR and controls were studied at the age of 6 months and rats transgenic for the human renin-angiotensin system (hrTGR) from postnatal day 1 to week 8. SHR and mrTGR had an increased heart/body weight ratio (26 and 25%) compared with controls (p < 0.05). SHR hearts showed significantly increased mRNA levels of delta4 and delta9 (p < 0.05) with no change for delta2 and delta3. mrTGR hearts had a significantly increased delta4 and a significantly decreased delta3 transcript level (p < 0.05) with no change for delta2 and delta9. hrTGR hearts developed severe hypertrophy (42%) after postnatal day 14. The neonatal delta2, delta3 and delta4 isoform expression levels were higher (30-100%) compared with SD controls. The levels decreased with increasing age and equalized to controls at week 8, except for delta4 which started to increase after week 4 (p < 0.05). CaMKIIdelta protein levels of all cardiac hypertrophy models were increased in sarcoplasmic reticulum preparations (50-120%) compared with controls (p < 0.05) while the cytosolic levels remained unchanged. Thus, CaMKIIdelta isoforms are differentially expressed in cardiac hypertrophy. The fetal delta4 isoform was constantly expressed. CaMKIIdelta adopts the fetal phenotype independent of the type of hypertrophic stimulus. The observed alterations of CaMKIIdelta isoform patterns may affect intracellular Ca2+ homeostasis and thus contribute to the abnormal contractile phenotype of cardiac hypertrophy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11451385     DOI: 10.1023/a:1010899724222

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  39 in total

Review 1.  Prevention of cardiac hypertrophy by calcineurin inhibition: hope or hype?

Authors:  E N Olson; J D Molkentin
Journal:  Circ Res       Date:  1999-04-02       Impact factor: 17.367

2.  Cardiac hypertrophy in spontaneously hypertensive rats.

Authors:  S Sen; R C Tarazi; P A Khairallah; F M Bumpus
Journal:  Circ Res       Date:  1974-11       Impact factor: 17.367

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 4.  The multifunctional calcium/calmodulin-dependent protein kinase: from form to function.

Authors:  A P Braun; H Schulman
Journal:  Annu Rev Physiol       Date:  1995       Impact factor: 19.318

5.  Sarcoplasmic reticulum Ca(2+)/Calmodulin-dependent protein kinase is altered in heart failure.

Authors:  T Netticadan; R M Temsah; K Kawabata; N S Dhalla
Journal:  Circ Res       Date:  2000-03-17       Impact factor: 17.367

6.  Identification of novel isoforms of the delta subunit of Ca2+/calmodulin-dependent protein kinase II. Differential expression in rat brain and aorta.

Authors:  C M Schworer; L I Rothblum; T J Thekkumkara; H A Singer
Journal:  J Biol Chem       Date:  1993-07-05       Impact factor: 5.157

7.  Multifunctional Ca2+/calmodulin-dependent protein kinase mediates Ca(2+)-induced enhancement of the L-type Ca2+ current in rabbit ventricular myocytes.

Authors:  M E Anderson; A P Braun; H Schulman; B A Premack
Journal:  Circ Res       Date:  1994-11       Impact factor: 17.367

8.  Phosphorylation and activation of the Ca(2+)-pumping ATPase of cardiac sarcoplasmic reticulum by Ca2+/calmodulin-dependent protein kinase.

Authors:  A Xu; C Hawkins; N Narayanan
Journal:  J Biol Chem       Date:  1993-04-25       Impact factor: 5.157

9.  Effects of angiotensin II on intracellular Ca2+ and pH in isolated beating rabbit hearts and myocytes loaded with the indicator indo-1.

Authors:  H Ikenouchi; W H Barry; J H Bridge; E O Weinberg; C S Apstein; B H Lorell
Journal:  J Physiol       Date:  1994-10-15       Impact factor: 5.182

10.  Alternative splicing introduces a nuclear localization signal that targets multifunctional CaM kinase to the nucleus.

Authors:  M Srinivasan; C F Edman; H Schulman
Journal:  J Cell Biol       Date:  1994-08       Impact factor: 10.539

View more
  21 in total

1.  A β(IV)-spectrin/CaMKII signaling complex is essential for membrane excitability in mice.

Authors:  Thomas J Hund; Olha M Koval; Jingdong Li; Patrick J Wright; Lan Qian; Jedidiah S Snyder; Hjalti Gudmundsson; Crystal F Kline; Nathan P Davidson; Natalia Cardona; Matthew N Rasband; Mark E Anderson; Peter J Mohler
Journal:  J Clin Invest       Date:  2010-09-27       Impact factor: 14.808

2.  Role of activated CaMKII in abnormal calcium homeostasis and I(Na) remodeling after myocardial infarction: insights from mathematical modeling.

Authors:  Thomas J Hund; Keith F Decker; Evelyn Kanter; Peter J Mohler; Penelope A Boyden; Richard B Schuessler; Kathryn A Yamada; Yoram Rudy
Journal:  J Mol Cell Cardiol       Date:  2008-06-28       Impact factor: 5.000

Review 3.  Mechanisms of altered Ca²⁺ handling in heart failure.

Authors:  Min Luo; Mark E Anderson
Journal:  Circ Res       Date:  2013-08-30       Impact factor: 17.367

4.  Stretch current-induced abnormal impulses in CaMKIIδ knockout mouse ventricular myocytes.

Authors:  Dongwu Lai; Lin Xu; Jun Cheng; Arnaud B Guilbert; Hyun Joung Lim; Guosheng Fu; Yanggan Wang
Journal:  J Cardiovasc Electrophysiol       Date:  2012-12-21

5.  Ryanodine receptor phosphorylation and heart failure: phasing out S2808 and "criminalizing" S2814.

Authors:  Héctor H Valdivia
Journal:  Circ Res       Date:  2012-05-25       Impact factor: 17.367

Review 6.  CaMKII in the cardiovascular system: sensing redox states.

Authors:  Jeffrey R Erickson; B Julie He; Isabella M Grumbach; Mark E Anderson
Journal:  Physiol Rev       Date:  2011-07       Impact factor: 37.312

7.  Residual Cx45 and its relationship to Cx43 in murine ventricular myocardium.

Authors:  Mingwei Bao; Evelyn M Kanter; Richard Y-C Huang; Stephan Maxeiner; Marina Frank; Yan Zhang; Richard B Schuessler; Timothy W Smith; R Reid Townsend; Henry W Rohrs; Viviana M Berthoud; Klaus Willecke; James G Laing; Kathryn A Yamada
Journal:  Channels (Austin)       Date:  2011-11-01       Impact factor: 2.581

8.  Reductions in the Cardiac Transient Outward K+ Current Ito Caused by Chronic β-Adrenergic Receptor Stimulation Are Partly Rescued by Inhibition of Nuclear Factor κB.

Authors:  Brian K Panama; Adam S Korogyi; Roozbeh Aschar-Sobbi; Yena Oh; Charles B B Gray; Hongying Gang; Joan Heller Brown; Lorrie A Kirshenbaum; Peter H Backx
Journal:  J Biol Chem       Date:  2016-01-07       Impact factor: 5.157

9.  Ca2+/calmodulin-dependent protein kinase II-dependent remodeling of Ca2+ current in pressure overload heart failure.

Authors:  Yanggan Wang; Samvit Tandan; Jun Cheng; Chunmei Yang; Lan Nguyen; Jessica Sugianto; Janet L Johnstone; Yuyang Sun; Joseph A Hill
Journal:  J Biol Chem       Date:  2008-07-11       Impact factor: 5.157

Review 10.  Ryanodine receptor-mediated arrhythmias and sudden cardiac death.

Authors:  Lynda M Blayney; F Anthony Lai
Journal:  Pharmacol Ther       Date:  2009-04-01       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.